ZBHZimmer Biomet
Is it safe?
Strong, no red flags: a safe balance sheet and clean books.
Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).
Mixed fundamental signals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.
Insiders were net sellers (-$824K, 90 days to Oct 8, 2026), selling is often routine.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Moderate price swings, typical volatility. Worst drawdown -52% · now 14% below its 52-week high.
Unless marked, from SEC EDGAR, as of Dec 31, 2025.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can ZBH take a bad year?
Zimmer Biomet carries $7.07B of net debt at 3.06× EBITDA: a load its earnings can carry.
Net debt · as at Q2 2026 · between two and four years of EBITDA, normal for a stable business
- Net debt / EBITDA
- 3.06×
Net debt / EBITDA · 3.05× a year ago · the load is going up
- Altman Z-score
- 2.37
Altman Z-score · grey zone, between 1.8 and 3
- Debt / equity
- 0.59×
Debt / equity
Details›
- Total debtQ2 2026
- $7.48B
- Cash and short-term investments
- $410M
- Net debt
- $7.07B
- EBITDA, trailing twelve months
- $2.31B
- Operating profit, trailing twelve months
- $1.21B
- Debt / equity
- 0.59×
- Total debt / EBITDA
- 3.23×
- Annualised volatilitytwo years of daily moves
- 29%
- Worst drawdown on file
- −52%
- Below its 52-week high
- 14%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Devices
The closest names by size in the same industry